Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Feifer

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Current Oncology (Toronto, Ont.)|March 27, 2026
Outcomes and Predictors of Recurrence and Survival in Surgically Resected Localized Chromophobe Renal Cell Carcinoma: Results from the Canadian Kidney Cancer Information System (CKCis)Erica Arenovich, Rodney Breau, Ricardo Rendon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2018
Clinically Localized Prostate Cancer: ASCO Clinical Practice Guideline Endorsement of an American Urological Association/American Society for Radiation Oncology/Society of Urologic Oncology GuidelineJustin E Bekelman, R Bryan Rumble, Ronald C Chen, et al.
Current Oncology (Toronto, Ont.)|July 25, 2025
Pre-Implementation Assessment of a Sexual Health eClinic in Canadian Oncology CareTaylor Incze, Dalia Peres, Steven Guirguis, et al.
BJU International|November 19, 2025
Risk of metachronous upper tract urothelial carcinoma following non-muscle-invasive bladder cancerKeiran J C Pace, Jethro C C Kwong, Harkanwal Randhawa, et al.
BJU International|May 26, 2025
Impact of concomitant carcinoma in situ distribution on non-muscle-invasive bladder cancer progression riskJethro C C Kwong, Keiran Pace, Zizo Al-Daqqaq, et al.
Future Oncology (London, England)|June 19, 2026
Outcomes of a Canadian real-world cohort of metastatic castration-sensitive prostate cancer patients stratified by early PSA nadirMichael Ong, Christopher Morash, Robert J Hamilton, et al.
The Lancet. Digital Health|May 21, 2023
Development, multi-institutional external validation, and algorithmic audit of an artificial intelligence-based Side-specific Extra-Prostatic Extension Risk Assessment tool (SEPERA) for patients undergoing radical prostatectomy: a retrospective cohort studyJethro C C Kwong, Adree Khondker, Eric Meng, et al.
European Urology|October 8, 2025
Development and International Evaluation of an Artificial Intelligence-based Model (PROGRxN-BCa) Using the World Health Organization 2004/2022 Grading System to Predict Progression Risk and Improve Substratification for Non-muscle-invasive Bladder CancerJethro C C Kwong, Zizo Al-Daqqaq, Yashan Chelliahpillai, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 26, 2023
Genetic testing practices among specialist physicians who treat prostate cancer A Canadian, cross-sectional surveySteven M Yip, Christopher Morash, Michael P Kolinsky, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Current Oncology (Toronto, Ont.)|March 27, 2026
Outcomes and Predictors of Recurrence and Survival in Surgically Resected Localized Chromophobe Renal Cell Carcinoma: Results from the Canadian Kidney Cancer Information System (CKCis)Erica Arenovich, Rodney Breau, Ricardo Rendon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2018
Clinically Localized Prostate Cancer: ASCO Clinical Practice Guideline Endorsement of an American Urological Association/American Society for Radiation Oncology/Society of Urologic Oncology GuidelineJustin E Bekelman, R Bryan Rumble, Ronald C Chen, et al.
Current Oncology (Toronto, Ont.)|July 25, 2025
Pre-Implementation Assessment of a Sexual Health eClinic in Canadian Oncology CareTaylor Incze, Dalia Peres, Steven Guirguis, et al.
BJU International|November 19, 2025
Risk of metachronous upper tract urothelial carcinoma following non-muscle-invasive bladder cancerKeiran J C Pace, Jethro C C Kwong, Harkanwal Randhawa, et al.
BJU International|May 26, 2025
Impact of concomitant carcinoma in situ distribution on non-muscle-invasive bladder cancer progression riskJethro C C Kwong, Keiran Pace, Zizo Al-Daqqaq, et al.
Future Oncology (London, England)|June 19, 2026
Outcomes of a Canadian real-world cohort of metastatic castration-sensitive prostate cancer patients stratified by early PSA nadirMichael Ong, Christopher Morash, Robert J Hamilton, et al.
The Lancet. Digital Health|May 21, 2023
Development, multi-institutional external validation, and algorithmic audit of an artificial intelligence-based Side-specific Extra-Prostatic Extension Risk Assessment tool (SEPERA) for patients undergoing radical prostatectomy: a retrospective cohort studyJethro C C Kwong, Adree Khondker, Eric Meng, et al.
European Urology|October 8, 2025
Development and International Evaluation of an Artificial Intelligence-based Model (PROGRxN-BCa) Using the World Health Organization 2004/2022 Grading System to Predict Progression Risk and Improve Substratification for Non-muscle-invasive Bladder CancerJethro C C Kwong, Zizo Al-Daqqaq, Yashan Chelliahpillai, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 26, 2023
Genetic testing practices among specialist physicians who treat prostate cancer A Canadian, cross-sectional surveySteven M Yip, Christopher Morash, Michael P Kolinsky, et al.
Pageof 4